supported by the Medical Key Research Projects of Shanxi Province(No.2020XM02);the Local Science and Technology Development Funds Projects Guided by Central Government(No.YDZJSX2021C027);the Basic Research Program of Shanxi Province(No.202103021224370);the Key R&D Project of Shanxi Province[International Scientific and Technological Cooperation,Independent Topics,(No.201903D421061)];Wu Jieping Medical Foundation(No.320.6750.2021-08-10).
Our prior investigations have established that Inonotus obliquus(Chaga)possesses hypoglycemic effects.Persistent hyperglycemia is known to precipitate renal function abnormalities.The functionality of the kidneys is i...
The research was sponsored by Vigonvita Life Sciences Co.,Ltd and was partially financially supported by a grant from the National Natural Science Foundation of China(No.81903701).
TPN171 is a novel phosphodiesterase-5(PDE5)inhibitor used to treat pulmonary arterial hypertension(PAH)and erectile dysfunction(ED),which currently is undergoing phase II clinical trials in China.In this single-center...